News
New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel "Neoantigen"
Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers. The focus of the study, published
Biochemist Peter Walter Receives 2018 Breakthrough Prize in Life Sciences
Peter Walter, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named winner of a 2018 Breakthrough Prize in Life Sciences, for his research on a biological mechanism that normally protects cells, but can cause disease if not functioning properly. The Breakthrough Prizes
Sugar Industry Suppressed Evidence of Health Risks of Sucrose
The sugar industry buried scientific research almost 50 years ago that pointed to negative health effects of sugar, ceasing funding the research when it reflected negatively on the industry's interests, according to a new UC San Francisco study. In a study to be published Nov. 21, 2017 in PLOS
HDFCCC Global Cancer Team Visits Tanzanian Partners
In September, Katherine Van Loon, MD, MPH, assistant professor in hematology/oncology and director of the HDFCCC Global Cancer Program, led a group of UCSF faculty and trainees to Tanzania to meet with stakeholders at the Muhimbili University of Health and Allied Sciences (MUHAS) and Ocean Road
Cell Mapping Initiatives Aim to Uncover Hidden Pathways of Disease
Nevan Krogan, PhD, is a mapmaker, but the object of his exploration is not any newfound continent or alien world. Instead, he and his colleagues map cells. Rather than cities, towns and interstates, these maps show proteins, genes, and the shifting, convoluted network of interactions between them
Anna Maria Nápoles Appointed Scientific Director of NIMHD
The National Institute on Minority Health and Health Disparities (NIMHD) has appointed Anna Maria Nápoles, PhD, MPH, as scientific director of its Division of Intramural Research. Nápoles, a UC San Francisco behavioral epidemiologist, is the first Latina to be named a scientific director at the
Deadly Lung Cancers are Driven by Multiple Genetic Changes
A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver” mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world’s most deadly forms of lung cancer is driven by changes in